Current Ratio in % of Trevi Therapeutics, Inc. from Q3 2019 to Q3 2025

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Trevi Therapeutics, Inc. quarterly Current Ratio history and change rate from Q3 2019 to Q3 2025.
Trevi Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 1.74K %, a 54.5% increase year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Change (%)

Trevi Therapeutics, Inc. Quarterly Current Ratio (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	1.74K	+614	+54.5%	30 Sep 2025
Q2 2025	1.37K	-65	-4.53%	30 Jun 2025
Q1 2025	1.07K	-637	-37.4%	31 Mar 2025
Q4 2024	1.03K	-337	-24.7%	31 Dec 2024
Q3 2024	1.13K	-52.4	-4.44%	30 Sep 2024
Q2 2024	1.43K	+427	+42.3%	30 Jun 2024
Q1 2024	1.7K	+920	+117%	31 Mar 2024
Q4 2023	1.37K	+728	+114%	31 Dec 2023
Q3 2023	1.18K	+684	+139%	30 Sep 2023
Q2 2023	1.01K	+658	+188%	30 Jun 2023
Q1 2023	783	+478	+157%	31 Mar 2023
Q4 2022	638	+239	+59.8%	31 Dec 2022
Q3 2022	494	-27.6	-5.29%	30 Sep 2022
Q2 2022	350	-339	-49.2%	30 Jun 2022
Q1 2022	305	-494	-61.8%	31 Mar 2022
Q4 2021	399	-387	-49.2%	31 Dec 2021
Q3 2021	522	-329	-38.6%	30 Sep 2021
Q2 2021	690	-241	-25.9%	30 Jun 2021
Q1 2021	799	-234	-22.6%	31 Mar 2021
Q4 2020	787	-235	-23%	31 Dec 2020
Q3 2020	850	-36	-4.06%	30 Sep 2020
Q2 2020	931			30 Jun 2020
Q1 2020	1.03K			31 Mar 2020
Q4 2019	1.02K			31 Dec 2019
Q3 2019	886			30 Sep 2019

* An asterisk sign (*) next to the value indicates that the value is likely invalid.